A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients

Table 3 Multivariate Cox analysis for 88 patients

Multivariate Cox regression
Factor	P	HR	95% CI
			Lower	Upper
INSS Stage (1-3, 4S vs 4)	0.002	7.15	2.08	24.64
NB-hypo	0.007	2.73	1.31	5.69
Age (< 1y vs > 1y)	0.801
MYCN (normal vs amplified)	0.671

ISSN: 1476-4598